Publications
5891 Results
- Journal / Conference
- Biometrics 51:249-258
- Year
- 1995
An implicitly defined parametric model for censored survival data and covariates
- Journal / Conference
- Cancer Investigation 13(Suppl.1):43(#36)
- Year
- 1995
- Research Committee(s)
- Cancer Control
- Study Number(s)
- SWOG-9217
Chemoprevention of prostate cancer with finasteride: An Intergroup trial
- Journal / Conference
- Seminars in Urology 13(2):122-129
- Year
- 1995
- Research Committee(s)
- Cancer Control
- Study Number(s)
- SWOG-9217
Chemoprevention of prostate cancer.
- Journal / Conference
- Journal of the National Cancer Institute 87(16):1254-1256
- Year
- 1995
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8294 (INT-0011) (EST-1180)
Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancer.
- Journal / Conference
- Journal of the American Academy of Dermatology 33(3):532-534
- Year
- 1995
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-8393 (INT-0013)
A centimeter here, a centimeter there: Does it matter?
- Journal / Conference
- Blood 86(10)(Suppl.1)(#1061):269a
- Year
- 1995
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-9031
MDR1 expression is highly predictive for achievement of complete remission (CR) in acute myeloid leukemia (AML) in the elderly: A Southwest Oncology Group study.
- Journal / Conference
- AUA Update Series (Lesson 29) 14:234-240
- Year
- 1995
- Research Committee(s)
- Genitourinary
Immunotherapy of superficial bladder carcinoma.
- Journal / Conference
- Journal of Clinical Oncology 13:797-798
- Year
- 1995
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9038
The price of success.
- Journal / Conference
- Leukemia 9(3):535(#O31)
- Year
- 1995
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-8600, SWOG-9007
Multidrug resistance (MDR1) expression and function in acute myeloid leukemia (AML) in the elderly: MDR1 and secondary AML status are independent predictors of complete remission (CR).
- Journal / Conference
- Blood 86(10)(Suppl.1)(#2902):729a
- Year
- 1995
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-9129 (INT-0129)